NCT00353496 2025-03-05
CLARINET
Ipsen
Phase 3 Completed
Clinical Trials
10 trialsNCT02795858 2025-02-19
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02859064 2023-12-05
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
SCRI Development Innovations, LLC
Phase 2 Terminated
NCT00774930 2022-10-14
ELECT
Ipsen
Phase 3 Completed
NCT00842348 2022-10-12
NET729
Ipsen
Phase 3 Completed
NCT02683941 2022-07-06
SPINET
Ipsen
Phase 3 Terminated
NCT01861717 2021-09-30
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
Saint John's Cancer Institute
Phase 4 Terminated
NCT02698410 2020-10-01
ATLANT
Ipsen
Phase 2 Completed
NCT00681187 2019-11-22
SAPHE
Ipsen
Phase 4 Completed
NCT01313273 2019-11-22
POSEIDON
Ipsen
Phase 3 Terminated